Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Medical Interface|September 4, 1996
Selected topical antifungal use in managed careS J Rich, A N GrudzinskiExpert Opinion on Pharmacotherapy|February 5, 2002
Considerations in the treatment of anxiety disorders: a pharmacoeconomic reviewA N GrudzinskiPharmacoeconomics|October 28, 1999
The economics of multiple sclerosis. Distribution of costs and relationship to disease severityA N Grudzinski, Z Hakim, E R Cox, et al.The American Journal of Managed Care|October 28, 1999
Course and cost of treatment for depression with fluoxetine, paroxetine, and sertralineJ M Russell, E R Berndt, R Miceli, et al.Cryobiology|August 1, 1991
The potential of an equimolar combination of propane-1,2-diol and glycerol as a vitrification solution for corneasS J Rich, W J ArmitageCryobiology|February 1, 1990
Propane-1,2-diol as a potential component of a vitrification solution for corneasS J Rich, W J ArmitageCryobiology|April 1, 1991
Corneal tolerance of vitrifiable concentrations of propane-1,2-diolS J Rich, W J ArmitageCryobiology|April 1, 1992
Corneal tolerance of vitrifiable concentrations of glycerolS J Rich, W J ArmitageValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 9, 2006
Comparing SSRI treatment costs for depression using retrospective claims data: the role of nonrandom selection and skewed dataE R Berndt, J M Russell, R Miceli, et al.The Journal of Clinical Psychiatry|October 30, 2001
The effect of selective serotonin reuptake inhibitor treatment of panic disorder on emergency room and laboratory resource utilizationP P Roy-Byrne, C M Clary, R J Miceli, et al.Pageof 2